Harrow Health (NASDAQ:HROW) posted its quarterly earnings results on Tuesday. The company reported $0.77 EPS for the quarter, missing the consensus estimate of $0.84 by ($0.07), Fidelity Earnings reports. The firm had revenue of $11.38 million during the quarter, compared to analyst estimates of $10.92 million. Harrow Health had a negative net margin of 16.81% and a negative return on equity of 231.16%.
Shares of HROW traded down $0.92 during mid-day trading on Thursday, reaching $5.13. The company had a trading volume of 457,534 shares, compared to its average volume of 213,687. Harrow Health has a twelve month low of $1.71 and a twelve month high of $7.20. The company has a current ratio of 1.13, a quick ratio of 0.88 and a debt-to-equity ratio of 2.84. The stock has a market cap of $158.52 million, a PE ratio of -8.55 and a beta of 0.07.
Separately, Zacks Investment Research cut Harrow Health from a “hold” rating to a “sell” rating in a report on Wednesday.
COPYRIGHT VIOLATION NOTICE: “Harrow Health (HROW) Issues Quarterly Earnings Results” was originally published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/4221070/harrow-health-hrow-issues-quarterly-earnings-results.html.
Harrow Health Company Profile
Harrow Health, Inc owns a portfolio of healthcare businesses, primarily ophthalmology pharmaceutical compounding business, ImprimisRx, in the United States. It develops, produces, and sells medications, including ophthalmology focused compounding formulations; and sterile and non-sterile compounded medications to physicians and patients.
Further Reading: What is cost of equity?
Receive News & Ratings for Harrow Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Harrow Health and related companies with MarketBeat.com's FREE daily email newsletter.